Aptevo Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aptevo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aptevo Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aptevo Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17k | 92k | 0.18 |
| 2023-09-30 | $73k | 221k | 0.33 |
| 2023-06-30 | $334k | 229k | 1.46 |
| 2023-03-31 | $467k | 229k | 2.04 |
| 2022-12-31 | $555k | 239k | 2.32 |
| 2022-06-30 | $855k | 239k | 3.58 |
| 2022-03-31 | $1.4M | 241k | 5.87 |
| 2021-09-30 | $2.1M | 135k | 15.44 |
| 2021-06-30 | $3.0M | 135k | 21.90 |
| 2021-03-31 | $4.1M | 131k | 31.02 |
| 2020-12-31 | $5.5M | 151k | 36.50 |
| 2020-09-30 | $565k | 75k | 7.59 |
| 2020-06-30 | $494k | 59k | 8.35 |
| 2020-03-31 | $223k | 60k | 3.70 |